BioSpace News Archive

Business

Vical Announces News Release and Conference Call Schedule for Third Quarter 2017 Financial Results

Vical will report financial results for the three months ended September 30, 2017, before the opening of trading on Monday, October 23.

October 17, 2017

·

1 min read

Ablynx Announces Launch Of Proposed Global Offering

Ablynx intends to offer and sell, subject to market and other conditions, approximately $175 million of its ordinary shares in a global offering.

October 17, 2017

·

6 min read

Bio NC

Inivata Highlights New Clinical Data on InVision(TM) ctDNA Liquid Biopsy Platform in Advanced NSCLC at WCLC 2017

This is the first data published using amplicon-based technology to detect ALK and ROS1 fusions.

October 17, 2017

·

3 min read

Transgene Presents First Clinical Data Indicating That TG1050 Induces A Robust And HBV-Specific Cell-Mediated Immune Response In Patients With Chronic Hepatitis B

Transgene, a biotech company that designs and develops viral-based immunotherapies, will be presenting a poster on TG1050 first promising clinical results at the American Association for the Study of Liver Diseases (AASLD) Meeting 2017, in Washington, DC, October 20-24.

October 17, 2017

·

6 min read

Bio NC

CEM Introduces the Future of Molecular Sample Preparation

CEM is pleased to introduce the all new EDGE extraction system for rapid sample preparation of GC/LC samples.

October 17, 2017

·

2 min read

NRGene Technology Efficiently Analyzes Abnormalities in Multiple Human Genomes

NRGene has demonstrated its ability to discover, analyze, and track abnormalities within the human genome, across multiple subjects.

October 17, 2017

·

2 min read

Drug Development

Xenon Pharmaceuticals Announces Initiation of XEN1101 Phase I Clinical Trial

Xenon’s innovative, proprietary epilepsy programs continue to advance in development.

October 17, 2017

·

8 min read

Business

Saniona’s Partner Cadent Therapeutics Receives Milestone From Novartis

Cadent Therapeutics also confirmed that it expects to initiate clinical development in 2018 for the program in collaboration with Saniona.

October 17, 2017

·

2 min read

BioMidwest

Abeona Therapeutics Announces Pricing of Public Offering of Common Stock

The gross offering size for this offering is expected to be approximately $80 million.

October 17, 2017

·

4 min read

Drug Development

Tonix Pharmaceuticals Reports Outcomes From U.S. FDA Breakthrough Therapy CMC Guidance Meeting of Tonmya (Cyclobenzaprine HCI Sublingual Tablets) for PTSD

Tonix is in Phase 3 development of Tonmya, an FDA-designated Breakthrough Therapy for the treatment of PTSD.

October 17, 2017

·

5 min read